Analysis of a biallelic polymorphism in the tumor necrosis factor α promoter and HIV type 1 disease progression

AIDS Research and Human Retroviruses

Volumn 14, Issue 4, 1998, Pages 305-309

  Knuchel, Marlyse C ^a   Spira, Thomas J ^a   Neumann, Avidan U ^b   Xiao, Lihua ^a   Rudolph, Donna L ^a   Phair, John ^c   Wolinsky, Steven M ^c   Koup, Richard A ^d   Cohen, Oren J ^e   Folks, Thomas M ^a   Lal, Renu B ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

^c NORTHWESTERN UNIVERSITY   (United States)

^d AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; IONOMYCIN; LIPOPOLYSACCHARIDE; MITOGENIC AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; STAPHYLOCOCCUS ENTEROTOXIN B; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOSEXUALITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0032030616     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.305     Document Type: Article

References (15)

1. Coffin JM: HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy. Science 1995;267: 483-489.
2. Wolinsky SM, Korber BTM, Neumann AU, et al.: Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 1996;272:537-542.
3. Haynes BF, Pantaleo G, and Fauci AS: Towards an understanding of the correlates of protective immunity to HIV infection. Science 1996;271:324-328.
4. Kaslow RA, Carrington M, Apple R, et al.: Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nature Med 1996;2:504-511.
5. Huang Y, Paxton WA, Wolinsky SM, et al.: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240-1243.
6. Wilson AG, de Vries N, Pociot F, diGiovine FS, van der Putte LBA, and Duff GW: An allelic polymorphism within the tumor necrosis factor a promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993;177:557-560.
7. McGuire W, Hills AVS, Allsopp CEM, Greenwood BM, and Kwjatkowski D: Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature (London) 1994;371:508-511.
8. Danis VA, Millington M, Hyland V, Lawford R, Huang Q, and Greenan D: Increased frequency of the uncommon allele of a tumor necrosis factor alpha gene polymorphism in rheumatoid arthritis and systematic lupus erythematosus. Dis Markers 1995; 12:127-133.
9. Bouma G, Crusius JBA, Pool MO, et al.: Secretion of tumor necrosis factor α and lymphotoxin α in relation to polymorphism in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel diseases. Scand J Immunol 1996;43:456-463.
10. Fishbein DB, Kaplan JE, Spira TJ, et al.: Unexplained lymphadenopathy in homosexual men. JAMA 1985;254:930-935.
11. Phair J, Jacobson L, Detels R, Rinaldo C, Saah A, Schrager L, and Munoiz A: Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: The multicenter AIDS cohort study. J Acquir Immune Defic Syndr 1992;5:490-496.
12. Wilson AG, diGiovine FS, Blakemore AL, and Duff GW: Single base polymorphism in the human tumor necrosis alpha (TNF alpha) gene detectable by Ncol restriction of PCR product. Hum Mol Genet 1992;1:353.
13. Stuber F, Udalvo IA, Book M, et al.: -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1996;46:42-50.
14. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, and Verweij CL: Relevance of the tumor necrosis factor alpha (TNFα) -308 promoter polymorphism in TNFα gene regulation. J Inflamm 1996;46:32-41.
15. Brinkman BMN, Keer IPM, Miedema F, Verweij CL, and Klein MR: Polymorphism within the tumor necrosis factor-α promoter region in human immunodeficiency virus type-1 seropositive persons. J Infect Dis 1997;175:188-190.